GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers | Communications Biology
Clinicopathological analysis of GATA3-positive breast cancers with special reference to response to neoadjuvant chemotherapy - ScienceDirect
Anti-GATA-3 Monoclonal Antibody(Clone: GATA3/2444)
Diagnostics | Free Full-Text | GATA3 as an Adjunct Prognostic Factor in Breast Cancer Patients with Less Aggressive Disease: A Study with a Review of the Literature
GATA3 is downregulated in HCC and accelerates HCC aggressiveness by transcriptionally inhibiting slug expression Corrigendum in /10.3892/ol.2021.12836
Expression of GATA3 in MDA-MB-231 Triple-negative Breast Cancer Cells Induces a Growth Inhibitory Response to TGFß | PLOS ONE
Good GATA3 Antibody for Flow Cytometry | Biocompare Antibody Review
GATA-3 (Center) (Breast and Urothelial Marker) Monoclonal Antibody (GATA3/6664) (2625-MSM13-P1)
Biological and Clinical Significance of GATA3 Detected from TCGA Datab | OTT
GATA-3 Links Tumor Differentiation and Dissemination in a Luminal Breast Cancer Model: Cancer Cell
Gata3 as a specific marker for canine Th2 cells and ILC2s. PBMCs were... | Download Scientific Diagram
Pathology Outlines - GATA3
GATA3 Antibody (EP368) - Bio SB
GATA3 (MSVA-450M) - MS Validated Antibodies
Pathology Outlines - GATA3
GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional network | Nature Communications
Anti-GATA-3 Monoclonal Antibody(Clone: GATA3/2442)
PDF) GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. | Piotr Czapiewski - Academia.edu
GATA3 - Wikipedia
Anti-GATA-3 Monoclonal Antibody(Clone: GATA3/2444)
GATA-3 (Center) (Breast and Urothelial Marker) Monoclonal Antibody (GATA3/6664) (2625-MSM13-P1)
Pathology Outlines - GATA3
Human GATA-3 PE-conjugated Antibody IC26051P: R&D Systems
Gata3 protein expression is lost during prostate cancer progression. (... | Download Scientific Diagram
Predictive markers for pathological complete response after neo-adjuvant chemotherapy in triple-negative breast cancer - ScienceDirect
